D5-Pharma SRL
3.0 FTED5-Pharma reported total assets of €1.49m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026), with 3 full-time equivalents.
The score of D5-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -73 % Total assets +210 % Headcount (avg FTE) +30 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
D5-Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 22 Jan 2025
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 07 Jul 2022
D5-Pharma's financial analysis
- Solvency7.8%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of D5-Pharma
D5-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0479.659.456
- VAT number
- BE0479659456
- Peppol
- Registered · 0208:0479659456 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Feb 2003
- Registered office
- 1083 Ganshoren
- Size
- Micro · 3.0 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
D5-Pharma (SRL) has been based in Ganshoren since 2003, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 26,472 € and equity of 115,485 €; its revenue is not published. With 3.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 7.8%, below the median of its sector (37.8%).
Companies similar to D5-Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Smets Retail sale of pharmaceutical products Herent · balance sheet €1.49m
- Pharmacie Deprez Retail sale of pharmaceutical products Charleroi · balance sheet €1.46m
- Marephar Retail sale of pharmaceutical products Lichtervelde · balance sheet €1.49m
- ENBA Retail sale of pharmaceutical products Bonheiden · balance sheet €1.48m
- VAN Holder Stephan Retail sale of pharmaceutical products Zottegem · balance sheet €1.48m
- DE Luchthaven Apotheek Retail sale of pharmaceutical products Zaventem · balance sheet €1.50m
- Binche Pharma Retail sale of pharmaceutical products Binche · balance sheet €1.51m
- Pharmart Retail sale of pharmaceutical products Etterbeek · balance sheet €1.51m
Frequently asked questions about D5-Pharma
What is the revenue of D5-Pharma?
D5-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of D5-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0479659456 for D5-Pharma, if the company is VAT-registered. Its company number (CBE) is 0479.659.456.
Where is the registered office of D5-Pharma?
According to the CBE register, the registered office of D5-Pharma is in 1083 Ganshoren.
What is the equity of D5-Pharma?
At the close of the 2025 financial year, the equity of D5-Pharma amounts to 115,485 €, a solvency of 7.8% of total assets.
How many people work at D5-Pharma?
3.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages D5-Pharma?
The register lists 2 active mandates at D5-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of D5-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →